Study to Assess the Potential for Adrenal Suppression Following Treatment With DSXS in Patients With Atopic Dermatitis
Clinical trial NCT02595008 · COMPLETED
Trial details
- NCT number
- NCT02595008
- Sponsor
- Sun Pharmaceutical Industries, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-28
- Primary completion
- 2017-02-22
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.